Chronic disease drug postoperative follow-up management method, device, equipment and medium
By collecting and preprocessing multi-dimensional data, entering the chronic disease drug label prediction model, and generating a postoperative follow-up management report, the problem of poor postoperative drug management in the existing technology is solved, and effective follow-up and resource optimization for chronic disease patients is achieved .
Patent Information
- Application Number
- CN202411114850.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-14
- Publication Date
- 2024-11-12
AI Technical Summary
The existing technology lacks effective postoperative follow-up plans in the follow-up management of chronic diseases, especially in the transition stage of outpatient hospitalization, which makes it difficult to early warning and deal with drug-related problems, resulting in unreasonable allocation of medical resources.
By collecting the target user's physiological data, situational data, clinical data and chronic disease data, preprocessing, inputting the chronic disease drug label prediction model, and generating a postoperative follow-up management report, including nutritional risk, pain management and risk assessment of drug-related problems. , provide medication recommendations and dietary advice.
Reasonable follow-up management of the use of chronic diseases after surgery has been achieved, the compliance of medical staff and the occupation of medical resources has been reduced, and the nutritional intake and pain management of patients has been improved.
Smart Images

Figure CN118942618A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of artificial intelligence technology, and in particular to a method, device, equipment and medium for postoperative follow-up management of chronic disease medication. Background Art
[0002] The full name of chronic disease is chronic non-communicable disease. It does not refer to a specific disease, but a general term for a class of diseases with hidden onset, long course and prolonged illness, lack of definite infectious biological etiology evidence, complex etiology, and some diseases that have not yet been fully confirmed. Common chronic diseases mainly include cardiovascular and cerebrovascular diseases, cancer, diabetes, and chronic respiratory diseases. Among them, cardiovascular and cerebrovascular diseases include hypertension, stroke and coronary artery atherosclerosis (CHD).
[0003] In the existing technology, when following up on chronic disease drugs, most of the collected and analyzed information needs to be actively uploaded by the patients themselves. Although this information is very useful, it is extremely dependent on the compliance of the patients themselves and it is difficult to play a real clinical value. In addition, the existing solutions lack the discovery and exploration of MRP (Medication Related Problem), especially when the patient is in the transition stage from outpatient to inpatient, there is no warning for the occurrence of MRP problems, there is no tiered treatment for the risk of MRP, the number of medical staff invested and the professional compliance are high, and it is impossible to achieve a reasonable allocation of medical resources.
[0004] There is still a lack of effective follow-up management plans for chronic disease medications after surgery. Summary of the invention
[0005] In view of the above, it is necessary to provide a method, device, equipment and medium for postoperative follow-up management of chronic disease drugs, aiming to solve the problem of ineffective follow-up management of chronic disease drugs after surgery.
[0006] A method for postoperative follow-up management of chronic disease medications, comprising:
[0007] In response to a chronic disease medication postoperative follow-up management instruction for a target user, collecting target physiological data, target situational data, target clinical data, and target chronic disease data of the target user as initial data;
[0008] Preprocessing the initial data to obtain data to be processed;
[0009] Inputting the data to be processed into a chronic disease drug label prediction model to obtain a label prediction result;
[0010] A postoperative follow-up management report on chronic disease medication for the target user is generated according to the tag prediction result.
[0011] According to a preferred embodiment of the present invention, the collecting of target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data includes:
[0012] Collecting physiological parameters and physiological signals of the target user as the target physiological data through a physiological data monitoring device;
[0013] Collecting the target user's lifestyle, disease situation and activity data during hospitalization as the target situation data; wherein the target situation data includes one or more of the following combinations: social data, daily activity data, network usage data, bad habit data, multimodal analgesia data, postoperative nausea and vomiting data, and nutritional intake data;
[0014] Collecting data used to construct a health profile of the target user as the target clinical data;
[0015] Acquire the chronic disease label, historical chronic disease medication data, and feedback data on used chronic disease medications of the target user as the target chronic disease data;
[0016] The target physiological data, the target situational data, the target clinical data and the target chronic disease data are integrated to obtain the initial data.
[0017] According to a preferred embodiment of the present invention, the preprocessing of the initial data includes:
[0018] Acquire positioning data in the daily activity data from the target context data, and analyze the positioning data to obtain the exercise type, exercise pattern, and exercise intensity of the target user;
[0019] Acquire sleep data in the daily activity data from the target context data, estimate at least one sleep stage of the target user based on the sleep data using a hidden Markov model, and model a transition process between two consecutive sleep stages in the at least one sleep stage as a Markov process of transition probability;
[0020] Normalizing the data of the numerical type in the initial data;
[0021] Performing word vectorization processing on image type data in the initial data;
[0022] Perform statistical analysis on the continuous monitoring type data in the initial data.
[0023] According to a preferred embodiment of the present invention, inputting the data to be processed into a chronic disease drug label prediction model to obtain a label prediction result includes:
[0024] Inputting the data to be processed into the chronic disease drug label prediction model, and obtaining output data of the chronic disease drug label prediction model;
[0025] The nutrition risk level label, chronic disease pain management label and drug-related problem risk level label are obtained from the output data to form the label prediction result.
[0026] According to a preferred embodiment of the present invention, before inputting the data to be processed into the chronic disease drug label prediction model, the method further includes:
[0027] Constructing the chronic disease drug label prediction model based on the T classifier;
[0028] The chronic disease drug label prediction model is expressed as follows:
[0029] V(result|Data)=T(Wp*Data+bp);
[0030] Among them, V (result|Data) represents the output data of the chronic disease drug label prediction model; Data represents the data to be processed; Wp and bp represent the classifier parameters of the chronic disease drug label prediction model; T represents the activation function, and the activation function includes a combination of one or more of a linear function, a S-type function and a hyperbolic tangent function, and the activation function includes at least one of the linear functions.
[0031] According to a preferred embodiment of the present invention, generating a chronic disease medication postoperative follow-up management report for the target user according to the tag prediction result includes:
[0032] Detecting whether the target user's nutritional intake meets the standard according to the nutritional risk level label; generating a nutritional balance mark when the target user's nutritional intake meets the standard; or generating a nutritional imbalance mark when the target user's nutritional intake does not meet the standard, and generating a dietary recommendation table according to the target user's nutritional intake;
[0033] Generate a medical staff pain assistance treatment strategy table based on the chronic disease pain management label;
[0034] Generate a list of recommended chronic disease and postoperative related drugs according to the drug-related problem risk level label and the chronic disease pain management label;
[0035] Integrate the dietary recommendation form, the medical staff pain auxiliary treatment strategy form and the chronic disease and postoperative related drug recommendation list to obtain the postoperative follow-up management report of the chronic disease drug;
[0036] Among them, the recommended list of chronic disease and postoperative related drugs includes: chronic disease drugs, nutritional drugs, postoperative analgesics, and disease treatment drugs.
[0037] According to a preferred embodiment of the present invention, after obtaining the postoperative follow-up management report of the chronic disease medication, the method further includes:
[0038] Determine the interaction between each drug in the recommended list of chronic disease and postoperative related drugs according to the risk level label of the drug-related problem, and generate the interaction level of each drug according to the interaction between each drug;
[0039] Obtaining a pre-configured combination strategy matching model; wherein the combination strategy matching model is used to output a corresponding combination strategy according to the input drug interaction level;
[0040] Inputting the interaction level between each drug into the combination strategy matching model to obtain the combination strategy between each drug;
[0041] The interaction levels include contraindication level, severe level, moderate level, and slight level;
[0042] Among them, the combination strategies include prohibited combination corresponding to the contraindication level, cautious combination when necessary corresponding to the serious level, combination with mild effect corresponding to the moderate level, and combination without affecting the effectiveness and safety of the drugs corresponding to the mild level.
[0043] A chronic disease medication postoperative follow-up management device, the chronic disease medication postoperative follow-up management device comprising:
[0044] A collection unit, configured to collect target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data in response to a chronic disease medication postoperative follow-up management instruction for the target user;
[0045] A preprocessing unit, used for preprocessing the initial data to obtain data to be processed;
[0046] An input unit, used to input the data to be processed into a chronic disease drug label prediction model to obtain a label prediction result;
[0047] A generating unit is used to generate a chronic disease medication postoperative follow-up management report for the target user according to the tag prediction result.
[0048] A computer device, comprising:
[0049] a memory storing at least one instruction; and
[0050] A processor executes instructions stored in the memory to implement the method for postoperative follow-up management of chronic disease medications.
[0051] A computer-readable storage medium stores at least one instruction, and the at least one instruction is executed by a processor in a computer device to implement the postoperative follow-up management method for chronic disease medications.
[0052] It can be seen from the above technical solutions that the present invention can collect the target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data, so as to comprehensively collect multi-dimensional data for subsequent analysis, and further pre-process the initial data to obtain the data to be processed to improve the data quality, and input the data to be processed into the chronic disease drug label prediction model to obtain the label prediction result, combine the multi-dimensional data and artificial intelligence means to perform accurate label prediction, and generate the target user's chronic disease drug postoperative follow-up management report according to the label prediction results, so as to assist in the reasonable follow-up management of the use of postoperative chronic disease drugs. BRIEF DESCRIPTION OF THE DRAWINGS
[0053] Figure 1 It is a flow chart of a preferred embodiment of the postoperative follow-up management method of chronic disease medication of the present invention.
[0054] Figure 2 It is a functional module diagram of a preferred embodiment of the chronic disease medication postoperative follow-up management device of the present invention.
[0055] Figure 3 It is a structural schematic diagram of a computer device of a preferred embodiment of the present invention for implementing a method for postoperative follow-up management of chronic disease medication. DETAILED DESCRIPTION
[0056] In order to make the purpose, technical solutions and advantages of the present invention more clear, the present invention is described in detail below with reference to the accompanying drawings and specific embodiments.
[0057] like Figure 1 FIG. 1 is a flow chart of a preferred embodiment of the method for postoperative follow-up management of chronic disease medication according to the present invention. According to different requirements, the order of the steps in the flow chart can be changed, and some steps can be omitted.
[0058] The postoperative follow-up management method for chronic disease drugs is applied to one or more computer devices, which are devices that can automatically perform numerical calculations and / or information processing according to pre-set or stored instructions, and their hardware includes but is not limited to microprocessors, application specific integrated circuits (Application Specific Integrated Circuit, ASIC), programmable gate arrays (Field-Programmable Gate Array, FPGA), digital processors (Digital Signal Processor, DSP), embedded devices, etc.
[0059] The computer device may be any electronic product that can perform human-computer interaction with a user, such as a personal computer, a tablet computer, a smart phone, a personal digital assistant (PDA), a game console, an interactive network television (IPTV), a smart wearable device, etc.
[0060] The computer device may also include a network device and / or a user device, wherein the network device includes, but is not limited to, a single network server, a server group consisting of multiple network servers, or a cloud consisting of a large number of hosts or network servers based on cloud computing.
[0061] The server can be an independent server or a cloud server that provides basic cloud computing services such as cloud services, cloud databases, cloud computing, cloud functions, cloud storage, network services, cloud communications, middleware services, domain name services, security services, content delivery networks (CDN), as well as big data and artificial intelligence platforms.
[0062] Among them, Artificial Intelligence (AI) is the theory, method, technology and application system that uses digital computers or machines controlled by digital computers to simulate, extend and expand human intelligence, perceive the environment, acquire knowledge and use knowledge to obtain the best results.
[0063] AI basic technologies generally include sensors, dedicated AI chips, cloud computing, distributed storage, big data processing technology, operation / interaction systems, mechatronics, etc. AI software technologies mainly include computer vision technology, robotics technology, biometrics technology, speech processing technology, natural language processing technology, and machine learning / deep learning.
[0064] The network where the computer device is located includes but is not limited to the Internet, a wide area network, a metropolitan area network, a local area network, a virtual private network (VPN), etc.
[0065] The nursing staff, clinical staff, and health professionals mentioned in this technical plan refer to professionals whose current positions are in health technical work among all employees paid by health institutions, including Chinese medicine practitioners, Western medicine practitioners, senior doctors of integrated Chinese and Western medicine, nurses, Chinese medicine pharmacists, Western pharmacists, laboratory technicians, other technicians, Chinese medicine practitioners, Western medicine practitioners, nurses, midwives, Chinese medicine pharmacists, Western pharmacists, laboratory technicians, other technicians, other Chinese medicine practitioners, nurses, Chinese medicine pharmacists, Western pharmacists, laboratory technicians, other technicians, other Chinese medicine practitioners, nurses, Chinese medicine pharmacists, Western pharmacists, laboratory technicians, other primary health technical personnel.
[0066] S10, in response to a chronic disease medication postoperative follow-up management instruction for a target user, collecting target physiological data, target situational data, target clinical data, and target chronic disease data of the target user as initial data.
[0067] The target users may include patients suffering from chronic diseases.
[0068] Among them, the chronic disease drug postoperative follow-up management instruction can be automatically triggered when the surgical plan of the target user is detected, and can also be triggered by relevant medical staff according to actual needs.
[0069] In this embodiment, the collecting of the target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data includes:
[0070] Collecting physiological parameters and physiological signals of the target user as the target physiological data through a physiological data monitoring device;
[0071] Collecting the target user's lifestyle, disease situation and activity data during hospitalization as the target situation data; wherein the target situation data includes one or more of the following combinations: social data, daily activity data, network usage data, bad habit data, multimodal analgesia data, postoperative nausea and vomiting data, and nutritional intake data;
[0072] Collecting data used to construct a health profile of the target user as the target clinical data;
[0073] Acquire the chronic disease label, historical chronic disease medication data, and feedback data on used chronic disease medications of the target user as the target chronic disease data;
[0074] The target physiological data, the target situational data, the target clinical data and the target chronic disease data are integrated to obtain the initial data.
[0075] The physiological data monitoring equipment may include, but is not limited to: a smart bracelet, an electrocardiogram acquisition device, a weighing machine, etc.
[0076] The physiological parameters may include, but are not limited to: heart rate, respiratory rate, body temperature and other information related to physiological conditions.
[0077] The physiological signals may include, but are not limited to, central physiological signals, peripheral physiological signals and other physiological parameters. The central physiological signals may include electroencephalogram signals, magnetic brain signals, functional magnetic resonance imaging, etc.; the peripheral physiological signals may include electromyography signals, electrocardiogram signals, electrooculogram signals, galvanic skin response, respiratory signals, skin temperature signals, volume pulse waves, gastric electrical signals, blood pressure, heart sound signals, blood flow, oxygen partial pressure and carbon dioxide partial pressure, etc.
[0078] The target context data may include information about actions, locations, activities, attributes and / or other similar situations related or associated with the patient during the detection time period.
[0079] Specifically, the social data includes: chat records, phone records, etc. through various chat software.
[0080] Specifically, the daily activity data may include: daily exercise data, work records, etc.
[0081] Specifically, the network usage data may include: usage records of multimedia software, web browsing records, etc.
[0082] Specifically, the bad habit data may include: smoking data, drinking data, long-sitting data, etc.
[0083] Specifically, the multimodal analgesia data may include: using non-opioid drugs to replace part of the opioid dosage to achieve the combined use of multiple analgesics to manage the patient's pain treatment plan. Preoperative education also plays an important role. Patients can relieve pain by understanding their condition and making psychological predictions about postoperative pain. Compared with traditional analgesia models, large-scale and long-term use of opioids can easily cause adverse reactions, such as nausea and vomiting, slow recovery of gastrointestinal function, and affecting postoperative recovery of eating and activities. Pain is the most basic evaluation criterion for patient satisfaction, which is related to the patient's compliance with the treatment plan. It is worth noting that pain is a subjective feeling of the patient. There is currently no way to objectively evaluate pain, but pain can still be estimated through the patient's daily life performance.
[0084] Specifically, the postoperative nausea and vomiting data may include: postoperative nausea and vomiting is one of the most common postoperative complications, which will greatly affect the early postoperative recovery and slow down the patient's postoperative rehabilitation progress. Persistent nausea and vomiting will lead to more serious consequences, such as water and electrolyte disorders, aspiration pneumonia, wound dehiscence, etc. A variety of postoperative medications are related to nausea and vomiting, including opioid analgesics used during or after surgery, whether sufficient carbohydrates are supplemented before surgery to avoid fasting, a reasonable amount of fluid replacement, the use of volatile anesthetics, and whether COX-2 inhibitors or other non-steroidal anti-inflammatory drugs are used in combination to replace opioid receptor drugs.
[0085] Specifically, the nutritional intake data may include: daily eating habits, nutritional intake ratios, etc.
[0086] Among them, the target clinical data may include administrative and demographic information, diagnosis, treatment, prescription drugs, over-the-counter drugs, laboratory test results, etc. These data can be collected through a variety of channels, including electronic medical record systems, laboratory information management systems, clinical databases, etc. These clinical data are clinical notes written by health professionals, digital nurse records, or data reported by subjects and / or health professionals through follow-up, questionnaires, general surveys, health event reports, clinical event reports, etc. These data provide detailed information about the patient's health status and help to more comprehensively evaluate the patient's condition and treatment effect. Comprehensive analysis of this information can provide the medical team with a comprehensive patient health portrait, so as to better formulate personalized treatment plans and health management strategies.
[0087] Among them, the target chronic disease data may include chronic disease labels such as the name of the chronic disease, the duration of the chronic disease, family history of chronic diseases, as well as historical chronic disease medication data (type of medication used and medication time, etc.), feedback data on chronic disease medications used (such as efficacy), etc.
[0088] Through the above-mentioned embodiments, multi-dimensional data can be comprehensively collected, so that the data used for subsequent analysis is more comprehensive, thereby improving the accuracy of the analysis results.
[0089] S11, preprocessing the initial data to obtain data to be processed.
[0090] In this embodiment, the preprocessing of the initial data includes:
[0091] Acquire positioning data in the daily activity data from the target context data, and analyze the positioning data to obtain the exercise type, exercise pattern, and exercise intensity of the target user;
[0092] Acquire sleep data in the daily activity data from the target context data, estimate at least one sleep stage of the target user based on the sleep data using a hidden Markov model, and model a transition process between two consecutive sleep stages in the at least one sleep stage as a Markov process of transition probability;
[0093] Normalizing the data of the numerical type in the initial data;
[0094] Performing word vectorization processing on image type data in the initial data;
[0095] Perform statistical analysis on the continuous monitoring type data in the initial data.
[0096] Specifically, by preprocessing the data, meaningful data can be extracted from the original data.
[0097] For example, taking GPS (Global Positioning System) sensor data as an example, speed, position, and possible activity type (such as walking or running) can be derived. On the other hand, data from a three-axis raw accelerometer can be used to derive the subject's activity intensity and body position. For example, when the patient remains still, the raw acceleration is equivalent to the gravity. When the patient's body position changes, the accelerometer data on the x-axis, y-axis, and z-axis will also change accordingly. In addition, depending on the availability of data, preprocessing may also include processing of data from gyroscope instruments, light sensors, sound sensors, altimeters, conductivity meters, etc. This comprehensive processing process helps to extract key information, making subsequent analysis more accurate and practical.
[0098] For another example: after preprocessing, contextual data about sleep stages can be obtained. When a patient falls asleep, physiological data changes, such as decreased heart rate and respiratory rate, reduced body movement, and decreased core temperature. During sleep, certain clinical parameters are important for caregivers, such as a patient's inability to lie down properly or shortness of breath during sleep may be an important sign of worsening heart failure. This embodiment uses a hidden Markov model to accurately estimate the patient's sleep stages, and models the transition process between these stages as a Markov process of transition probabilities. It should be noted that the observed physiological and contextual data and the probabilities associated with each sleep stage may vary. By estimating the sleep stages, the patient's sleep condition can be explored more finely, while providing more personalized probability parameters for monitoring different sleep stages.
[0099] For another example: data preprocessing can also standardize the difference data, such as compressing the data to the range of 0 to 1 by linearly transforming the original data. For image report data, word2vec word vector technology is used to vectorize the image report data results. For daily continuous monitoring data (such as physiological data and situational data), ECG data can be used to calculate heart rate variability indicators, and blood pressure data from continuous monitoring can be used to calculate blood pressure variability indicators. Related statistics such as daily heart rate, blood pressure, blood sugar, exercise, and body fat ratio can also be calculated.
[0100] Through the above embodiments, data instructions and availability can be further improved to ensure that the subsequent analysis process is more accurate and targeted.
[0101] S12, inputting the data to be processed into a chronic disease drug label prediction model to obtain a label prediction result.
[0102] In this embodiment, the step of inputting the data to be processed into a chronic disease drug label prediction model to obtain a label prediction result includes:
[0103] Inputting the data to be processed into the chronic disease drug label prediction model, and obtaining output data of the chronic disease drug label prediction model;
[0104] The nutrition risk level label, chronic disease pain management label and drug-related problem risk level label are obtained from the output data to form the label prediction result.
[0105] Among them, the nutritional risk level label can reflect whether the nutritional intake of the target user meets the standard.
[0106] The chronic disease pain management label may reflect the pain probability and intensity of the target user.
[0107] Among them, the drug-related problem risk level label can reflect potential problems that have not yet caused any harm to the patient, but if not handled, may cause harm in the near future, such as differences in patient drug treatment regimens and poor drug compliance.
[0108] In this embodiment, the prescription can be automatically renewed according to the patient's medication habits, which can prevent the patient from abusing drugs during the pain management process while increasing patient compliance.
[0109] In this embodiment, before inputting the data to be processed into the chronic disease drug label prediction model, the method further includes:
[0110] Constructing the chronic disease drug label prediction model based on the T classifier;
[0111] The chronic disease drug label prediction model is expressed as follows:
[0112] V(result|Data)=T(W p *Data+b p );
[0113] Wherein, V(result|Data) represents the output data of the chronic disease drug label prediction model; Data represents the data to be processed; W p 、b p represents the classifier parameters of the chronic disease drug label prediction model; T represents the activation function, the activation function includes a combination of one or more of a linear function, a S-type function and a hyperbolic tangent function, and the activation function includes at least one of the linear functions.
[0114] Among them, V(result|Data) is used to generate evaluation indices corresponding to various labels.
[0115] Through the above embodiments, it is possible to combine artificial intelligence means and multi-dimensional data to achieve accurate prediction of labels, so as to facilitate subsequent analysis based on the labels.
[0116] S13, generating a chronic disease medication postoperative follow-up management report for the target user according to the tag prediction result.
[0117] In this embodiment, generating the chronic disease medication postoperative follow-up management report for the target user according to the tag prediction result includes:
[0118] Detecting whether the target user's nutritional intake meets the standard according to the nutritional risk level label; generating a nutritional balance mark when the target user's nutritional intake meets the standard; or generating a nutritional imbalance mark when the target user's nutritional intake does not meet the standard, and generating a dietary recommendation table according to the target user's nutritional intake;
[0119] Generate a medical staff pain assistance treatment strategy table based on the chronic disease pain management label;
[0120] Generate a list of recommended chronic disease and postoperative related drugs according to the drug-related problem risk level label and the chronic disease pain management label;
[0121] Integrate the dietary recommendation form, the medical staff pain auxiliary treatment strategy form and the chronic disease and postoperative related drug recommendation list to obtain the postoperative follow-up management report of the chronic disease drug;
[0122] Among them, the recommended list of chronic disease and postoperative related drugs includes: chronic disease drugs, nutritional drugs, postoperative analgesics, and disease treatment drugs.
[0123] In the above embodiment, the nutritional balance mark and the nutritional imbalance mark can intuitively reflect the nutritional intake of the target user. At the same time, a dietary recommendation table is generated when there is nutritional imbalance to assist the target user in eating a reasonable diet to ensure nutritional intake.
[0124] In the above embodiment, the medical staff pain assistance treatment strategy table can remind relevant medical staff to assist patients in alleviating pain, so as to enhance the patient's cooperation and alleviate the pain.
[0125] In the above embodiment, the chronic disease and postoperative related drug recommendation list can reasonably recommend medications, such as chronic disease drugs, nutritional drugs, postoperative analgesics, disease treatment drugs, etc., reducing the compliance with the number and professionalism of medical staff.
[0126] The chronic disease medication postoperative follow-up management report may also include a follow-up strategy for the patient to better manage the patient's postoperative condition in a timely manner.
[0127] In this embodiment, after obtaining the chronic disease medication postoperative follow-up management report, the method further includes:
[0128] Determine the interaction between each drug in the recommended list of chronic disease and postoperative related drugs according to the risk level label of the drug-related problem, and generate the interaction level of each drug according to the interaction between each drug;
[0129] Obtaining a pre-configured combination strategy matching model; wherein the combination strategy matching model is used to output a corresponding combination strategy according to the input drug interaction level;
[0130] Inputting the interaction level between each drug into the combination strategy matching model to obtain the combination strategy between each drug;
[0131] The interaction levels include contraindication level, severe level, moderate level, and slight level;
[0132] Among them, the combination strategies include prohibited combination corresponding to the contraindication level, cautious combination when necessary corresponding to the serious level, combination with mild effect corresponding to the moderate level, and combination without affecting the effectiveness and safety of the drugs corresponding to the mild level.
[0133] Through the above embodiments, the correlation between drugs can be further determined to avoid serious adverse reactions caused by medication errors.
[0134] This embodiment can not only provide effective early warning for the risk of MRP occurrence, but also reasonably configure the diet, pain auxiliary treatment strategies and related drugs for patients with chronic diseases. It can not only effectively follow up and manage patients with chronic diseases, but also effectively reduce the occupation of medical resources.
[0135] It can be seen from the above technical solutions that the present invention can collect the target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data, so as to comprehensively collect multi-dimensional data for subsequent analysis, and further pre-process the initial data to obtain the data to be processed to improve the data quality, and input the data to be processed into the chronic disease drug label prediction model to obtain the label prediction result, combine the multi-dimensional data and artificial intelligence means to perform accurate label prediction, and generate the target user's chronic disease drug postoperative follow-up management report according to the label prediction results, so as to assist in the reasonable follow-up management of the use of postoperative chronic disease drugs.
[0136] like Figure 2 , which is a functional module diagram of a preferred embodiment of the chronic disease drug postoperative follow-up management device of the present invention. The chronic disease drug postoperative follow-up management device 11 includes a collection unit 110, a preprocessing unit 111, an input unit 112, and a generation unit 113. The module / unit referred to in the present invention refers to a series of computer program segments that can be executed by a processor and can complete fixed functions, which are stored in a memory. In this embodiment, the functions of each module / unit will be described in detail in subsequent embodiments.
[0137] The acquisition unit 110 is used to collect target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data in response to a chronic disease medication postoperative follow-up management instruction for the target user;
[0138] The preprocessing unit 111 is used to preprocess the initial data to obtain data to be processed;
[0139] The input unit 112 is used to input the data to be processed into the chronic disease drug label prediction model to obtain a label prediction result;
[0140] The generating unit 113 is used to generate a chronic disease medication postoperative follow-up management report for the target user according to the tag prediction result.
[0141] It can be seen from the above technical solutions that the present invention can collect the target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data, so as to comprehensively collect multi-dimensional data for subsequent analysis, and further pre-process the initial data to obtain the data to be processed to improve the data quality, and input the data to be processed into the chronic disease drug label prediction model to obtain the label prediction result, combine the multi-dimensional data and artificial intelligence means to perform accurate label prediction, and generate the target user's chronic disease drug postoperative follow-up management report according to the label prediction results, so as to assist in the reasonable follow-up management of the use of postoperative chronic disease drugs.
[0142] like Figure 3 The figure is a schematic diagram of the structure of a computer device of a preferred embodiment of the present invention for implementing the postoperative follow-up management method of chronic disease medication.
[0143] The computer device 1 may include a memory 12, a processor 13 and a bus, and may also include a computer program stored in the memory 12 and executable on the processor 13, such as a postoperative follow-up management program for chronic disease medications.
[0144] Those skilled in the art will appreciate that the schematic diagram is merely an example of the computer device 1 and does not constitute a limitation on the computer device 1. The computer device 1 may be a bus-type structure or a star-type structure. The computer device 1 may also include more or less other hardware or software than shown in the diagram, or a different arrangement of components. For example, the computer device 1 may also include input and output devices, network access devices, etc.
[0145] It should be noted that the computer device 1 is only an example, and other existing or future electronic products that are suitable for the present invention should also be included in the protection scope of the present invention and included here by reference.
[0146] Among them, the memory 12 includes at least one type of readable storage medium, and the readable storage medium includes flash memory, mobile hard disk, multimedia card, card-type memory (for example: SD or DX memory, etc.), magnetic memory, disk, optical disk, etc. In some embodiments, the memory 12 can be an internal storage unit of the computer device 1, such as a mobile hard disk of the computer device 1. In other embodiments, the memory 12 can also be an external storage device of the computer device 1, such as a plug-in mobile hard disk, a smart memory card (Smart Media Card, SMC), a secure digital (SecureDigital, SD) card, a flash card (Flash Card), etc. equipped on the computer device 1. Further, the memory 12 can also include both an internal storage unit of the computer device 1 and an external storage device. The memory 12 can not only be used to store application software and various types of data installed in the computer device 1, such as the code of the chronic disease drug postoperative follow-up management program, but also can be used to temporarily store data that has been output or is to be output.
[0147] In some embodiments, the processor 13 may be composed of an integrated circuit, for example, a single packaged integrated circuit, or a plurality of packaged integrated circuits with the same or different functions, including one or more central processing units (CPUs), microprocessors, digital processing chips, graphics processors, and combinations of various control chips. The processor 13 is the control core (Control Unit) of the computer device 1, and uses various interfaces and lines to connect the various components of the entire computer device 1, and executes or executes programs or modules stored in the memory 12 (for example, executing a chronic disease drug postoperative follow-up management program, etc.), and calls the data stored in the memory 12 to execute various functions of the computer device 1 and process data.
[0148] The processor 13 executes the operating system of the computer device 1 and various installed application programs. The processor 13 executes the application programs to implement the steps in the above-mentioned various chronic disease medication postoperative follow-up management method embodiments, for example Figure 1 Steps shown.
[0149] Exemplarily, the computer program may be divided into one or more modules / units, which are stored in the memory 12 and executed by the processor 13 to complete the present invention. The one or more modules / units may be a series of computer-readable instruction segments capable of completing specific functions, which are used to describe the execution process of the computer program in the computer device 1. For example, the computer program may be divided into a collection unit 110, a preprocessing unit 111, an input unit 112, and a generation unit 113.
[0150] The above-mentioned integrated unit implemented in the form of a software function module can be stored in a computer-readable storage medium. The above-mentioned software function module is stored in a storage medium, and includes a number of instructions for enabling a computer device (which can be a personal computer, a computer device, or a network device, etc.) or a processor to execute the part of the postoperative follow-up management method for chronic disease drugs described in various embodiments of the present invention.
[0151] If the module / unit integrated in the computer device 1 is implemented in the form of a software functional unit and sold or used as an independent product, it can be stored in a computer-readable storage medium. Based on this understanding, the present invention implements all or part of the processes in the above-mentioned embodiment method, and can also be completed by instructing the relevant hardware devices through a computer program. The computer program can be stored in a computer-readable storage medium, and when the computer program is executed by a processor, the steps of each of the above-mentioned method embodiments can be implemented.
[0152] The computer program includes computer program code, which may be in source code form, object code form, executable file or some intermediate form, etc. The computer readable medium may include: any entity or device capable of carrying the computer program code, recording medium, USB flash drive, mobile hard disk, magnetic disk, optical disk, computer memory, read-only memory (ROM), random access memory, etc.
[0153] Furthermore, the computer-readable storage medium may mainly include a program storage area and a data storage area, wherein the program storage area may store an operating system, an application required for at least one function, etc.; the data storage area may store data created according to the use of the blockchain node, etc.
[0154] The blockchain referred to in this invention is a new application mode of computer technologies such as distributed data storage, peer-to-peer transmission, consensus mechanism, encryption algorithm, etc. Blockchain is essentially a decentralized database, a string of data blocks generated by cryptographic methods. Each data block contains a batch of network transaction information, which is used to verify the validity of its information (anti-counterfeiting) and generate the next block. Blockchain can include the underlying blockchain platform, platform product service layer, and application service layer.
[0155] The bus can be a peripheral component interconnect (PCI) bus or an extended industry standard architecture (EISA) bus. The bus can be divided into an address bus, a data bus, a control bus, etc. For ease of representation, Figure 3 The bus is represented by only one straight line, but it does not mean that there is only one bus or one type of bus. The bus is configured to realize the connection and communication between the memory 12 and at least one processor 13, etc.
[0156] Although not shown, the computer device 1 may also include a power source (such as a battery) for supplying power to each component. Preferably, the power source may be logically connected to the at least one processor 13 through a power management device, so that the power management device can realize functions such as charging management, discharging management, and power consumption management. The power source may also include any components such as one or more DC or AC power sources, recharging devices, power failure detection circuits, power converters or inverters, power status indicators, etc. The computer device 1 may also include a variety of sensors, Bluetooth modules, Wi-Fi modules, etc., which will not be repeated here.
[0157] Furthermore, the computer device 1 may also include a network interface. Optionally, the network interface may include a wired interface and / or a wireless interface (such as a WI-FI interface, a Bluetooth interface, etc.), which is usually used to establish a communication connection between the computer device 1 and other computer devices.
[0158] Optionally, the computer device 1 may further include a user interface, which may be a display, an input unit (such as a keyboard), or a standard wired interface or a wireless interface. Optionally, in some embodiments, the display may be an LED display, a liquid crystal display, a touch-sensitive liquid crystal display, or an OLED (Organic Light-Emitting Diode) touch device. The display may also be appropriately referred to as a display screen or a display unit, which is used to display information processed in the computer device 1 and to display a visual user interface.
[0159] It should be understood that the embodiment is for illustration only and the scope of the patent application is not limited to this structure.
[0160] Figure 3 Only the computer device 1 having components 12-13 is shown, and it can be understood by those skilled in the art that Figure 3 The structure shown does not constitute a limitation on the computer device 1, and may include fewer or more components than shown in the figure, or combine certain components, or arrange the components differently.
[0161] Combination Figure 1 The memory 12 in the computer device 1 stores a plurality of instructions to implement a method for postoperative follow-up management of chronic disease medications, and the processor 13 can execute the plurality of instructions to implement:
[0162] In response to a chronic disease medication postoperative follow-up management instruction for a target user, collecting target physiological data, target situational data, target clinical data, and target chronic disease data of the target user as initial data;
[0163] Preprocessing the initial data to obtain data to be processed;
[0164] Inputting the data to be processed into a chronic disease drug label prediction model to obtain a label prediction result;
[0165] A postoperative follow-up management report on chronic disease medication for the target user is generated according to the tag prediction result.
[0166] Specifically, the specific implementation method of the processor 13 for the above instructions can refer to Figure 1 The description of the relevant steps in the corresponding embodiments will not be repeated here.
[0167] It should be noted that the data involved in this case were all obtained legally.
[0168] In the several embodiments provided by the present invention, it should be understood that the disclosed systems, devices and methods can be implemented in other ways. For example, the device embodiments described above are only illustrative, for example, the division of the modules is only a logical function division, and there may be other division methods in actual implementation.
[0169] The present invention can be used in many general or special computer system environments or configurations. For example: personal computers, server computers, handheld or portable devices, tablet devices, multiprocessor systems, microprocessor-based systems, set-top boxes, programmable consumer electronic devices, network PCs, minicomputers, mainframe computers, distributed computing environments including any of the above systems or devices, etc. The present invention can be described in the general context of computer-executable instructions executed by a computer, such as program modules. Generally, program modules include routines, programs, objects, components, data structures, etc. that perform specific tasks or implement specific abstract data types. The present invention can also be practiced in distributed computing environments, in which tasks are performed by remote processing devices connected through a communication network. In a distributed computing environment, program modules can be located in local and remote computer storage media including storage devices.
[0170] The modules described as separate components may or may not be physically separated, and the components shown as modules may or may not be physical units, that is, they may be located in one place or distributed on multiple network units. Some or all of the modules may be selected according to actual needs to achieve the purpose of the solution of this embodiment.
[0171] In addition, each functional module in each embodiment of the present invention may be integrated into one processing unit, each unit may exist physically separately, or two or more units may be integrated into one unit. The above-mentioned integrated unit may be implemented in the form of hardware or in the form of hardware plus software functional modules.
[0172] It is obvious to those skilled in the art that the present invention is not limited to the details of the above exemplary embodiments, and that the present invention can be implemented in other specific forms without departing from the spirit or essential characteristics of the present invention.
[0173] Therefore, no matter from which point of view, the embodiments should be regarded as illustrative and non-restrictive, and the scope of the present invention is limited by the appended claims rather than the above description, so it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims are included in the present invention. Any attached figure mark in the claims should not be regarded as limiting the claims involved.
[0174] In addition, it is clear that the word "comprising" does not exclude other units or steps, and the singular does not exclude the plural. Multiple units or devices stated in the present invention can also be implemented by one unit or device through software or hardware. The words first, second, etc. are used to indicate names, and do not indicate any particular order.
[0175] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the spirit and scope of the technical solution of the present invention.
Claims
1. A method for follow-up management of chronic disease medication after surgery. It is characterized in that The postoperative follow-up management method for chronic disease medications includes: In response to a chronic disease medication postoperative follow-up management instruction for a target user, collecting target physiological data, target situational data, target clinical data, and target chronic disease data of the target user as initial data; Preprocessing the initial data to obtain data to be processed; Inputting the data to be processed into a chronic disease drug label prediction model to obtain a label prediction result; A postoperative follow-up management report on chronic disease medication for the target user is generated according to the tag prediction result.
2. The method for postoperative follow-up management of chronic disease medication according to claim 1, It is characterized in that The collecting of the target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data includes: Collecting physiological parameters and physiological signals of the target user as the target physiological data through a physiological data monitoring device; Collecting the target user's lifestyle, disease situation and activity data during hospitalization as the target situation data; wherein the target situation data includes one or more of the following combinations: social data, daily activity data, network usage data, bad habit data, multimodal analgesia data, postoperative nausea and vomiting data, and nutritional intake data; Collecting data used to construct a health profile of the target user as the target clinical data; Acquire the chronic disease label, historical chronic disease medication data, and feedback data on used chronic disease medications of the target user as the target chronic disease data; The target physiological data, the target situational data, the target clinical data and the target chronic disease data are integrated to obtain the initial data.
3. The method for postoperative follow-up management of chronic disease medication according to claim 2, It is characterized in that The preprocessing of the initial data comprises: Acquire positioning data in the daily activity data from the target context data, and analyze the positioning data to obtain the exercise type, exercise pattern, and exercise intensity of the target user; Acquire sleep data in the daily activity data from the target context data, estimate at least one sleep stage of the target user based on the sleep data using a hidden Markov model, and model a transition process between two consecutive sleep stages in the at least one sleep stage as a Markov process of transition probability; Normalizing the data of the numerical type in the initial data; Performing word vectorization processing on image type data in the initial data; Perform statistical analysis on the continuous monitoring type data in the initial data.
4. The method for postoperative follow-up management of chronic disease medication according to claim 1, It is characterized in that The step of inputting the data to be processed into the chronic disease drug label prediction model to obtain the label prediction result includes: Inputting the data to be processed into the chronic disease drug label prediction model, and obtaining output data of the chronic disease drug label prediction model; The nutrition risk level label, chronic disease pain management label and drug-related problem risk level label are obtained from the output data to form the label prediction result.
5. The method for postoperative follow-up management of chronic disease medication according to claim 1, It is characterized in that Before inputting the data to be processed into the chronic disease drug label prediction model, the method further includes: Constructing the chronic disease drug label prediction model based on the T classifier; The chronic disease drug label prediction model is expressed as follows: V(result|Data)=T(W p *Data+b p ); Wherein, V(result|Data) represents the output data of the chronic disease drug label prediction model; Data represents the data to be processed; W p 、b p represents the classifier parameters of the chronic disease drug label prediction model; T represents the activation function, the activation function includes a combination of one or more of a linear function, a S-type function and a hyperbolic tangent function, and the activation function includes at least one of the linear functions.
6. The method for postoperative follow-up management of chronic disease medication according to claim 4, It is characterized in that Generating the chronic disease medication postoperative follow-up management report for the target user according to the tag prediction result includes: Detecting whether the target user's nutritional intake meets the standard according to the nutritional risk level label; generating a nutritional balance mark when the target user's nutritional intake meets the standard; or generating a nutritional imbalance mark when the target user's nutritional intake does not meet the standard, and generating a dietary recommendation table according to the target user's nutritional intake; Generate a medical staff pain assistance treatment strategy table based on the chronic disease pain management label; Generate a list of recommended chronic disease and postoperative related drugs according to the drug-related problem risk level label and the chronic disease pain management label; Integrate the dietary recommendation form, the medical staff pain auxiliary treatment strategy form and the chronic disease and postoperative related drug recommendation list to obtain the postoperative follow-up management report of the chronic disease drug; Among them, the recommended list of chronic disease and postoperative related drugs includes: chronic disease drugs, nutritional drugs, postoperative analgesics, and disease treatment drugs.
7. The method for postoperative follow-up management of chronic disease medication according to claim 6, It is characterized in that After obtaining the postoperative follow-up management report of the chronic disease medication, the method further includes: Determine the interaction between each drug in the recommended list of chronic disease and postoperative related drugs according to the risk level label of the drug-related problem, and generate the interaction level of each drug according to the interaction between each drug; Obtaining a pre-configured combination strategy matching model; wherein the combination strategy matching model is used to output a corresponding combination strategy according to the input drug interaction level; Inputting the interaction level between each drug into the combination strategy matching model to obtain the combination strategy between each drug; The interaction levels include contraindication level, severe level, moderate level, and slight level; Among them, the combination strategies include prohibited combination corresponding to the contraindication level, cautious combination when necessary corresponding to the serious level, combination with mild effect corresponding to the moderate level, and combination without affecting the effectiveness and safety of the drugs corresponding to the mild level.
8. A chronic disease medication postoperative follow-up management device, It is characterized in that The chronic disease medication postoperative follow-up management device comprises: A collection unit, configured to collect target physiological data, target situational data, target clinical data and target chronic disease data of the target user as initial data in response to a chronic disease medication postoperative follow-up management instruction for the target user; A preprocessing unit, used for preprocessing the initial data to obtain data to be processed; An input unit, used to input the data to be processed into a chronic disease drug label prediction model to obtain a label prediction result; A generating unit is used to generate a chronic disease medication postoperative follow-up management report for the target user according to the tag prediction result.
9. A computer device, It is characterized in that The computer device comprises: a memory storing at least one instruction; and A processor executes instructions stored in the memory to implement the postoperative follow-up management method for chronic disease medications as described in any one of claims 1 to 7.
10. A computer-readable storage medium, Features: The computer-readable storage medium stores at least one instruction, and the at least one instruction is executed by a processor in a computer device to implement the postoperative follow-up management method for chronic disease medications as described in any one of claims 1 to 7.
